| Market Cap | ₹119Cr |
| ROE | 8.71% |
| P/E Ratio(TTM) | 17.39 |
| EPS(TTM) | 4.31 |
| P/B Ratio | 1.52 |
| Dividend Yield | 1.60% |
| Industry P/E | 33.32 |
| Book Value | 49.20 |
| Debt to Equity | 1.98 |
| Face Value | 10 |
| Parent Organisation | Bal Pharma |
| Managing Director | Shailesh Siroya |
| Founded | 1987 |
| NSE Symbol | BALPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.27 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.05 | ||
| Wockhardt | NA (0.00%) | -449.22 | ||
| Cohance Lifesciences | NA (0.00%) | 65.70 |